Purpose: To describe the involvement of the lacrimal gland (LG) in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES).
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Three decades later, Dimitry 2 defined its inheritance pattern as autosomal dominant, which was confirmed over subsequent years. Its molecular basis remained undetermined until 2001, when Crisponi et al 3 finally identified forkhead box protein L2 (FOXL2) (Online Mendelian Inheritance in Man *605597) on chromosome 3q23 as the causal gene. 3 This single-exon gene encodes a forkhead transcription factor expressed in the developing eyelid mesenchyme and fetal and adult ovaries. 4, 5 Thus, depending on its expression, there are 2 types of BPES: type I with premature ovarian failure and type II with normal ovary function. 6, 7 Severe ptosis with poor levator function, epicanthus inversus, and telecanthus are present in both types. We describe a significant spectrum of lacrimal gland (LG) changes in BPES. In addition, molecular analysis of FOXL2 was performed in 16 patients in an attempt to obtain new insights into a possible genotypeephenotype correlation.
Methods

Patients
The research adhered to the tenets of the Declaration of Helsinki. Approval was obtained from the Institutional Review Boards and Ethics Committees, and all subjects gave written informed consent to participate in the study.
Twenty-one patients with a clinical diagnosis of BPES were recruited from 1 Portuguese and 3 Brazilian medical centers. Mean age was 15 years (range, 2e39 years). Schirmer test I (without anesthesia) and slit-lamp biomicroscopy assessment of the lacrimal meniscus height and corneal fluorescein staining were performed in all patients. A Schirmer's test score <10 mm after 5 minutes with the eyes closed was considered as an indication of reduced aqueous tear production. 8, 9 Two radiologists measured LG volumes on computed tomography (CT) scans using OsiriX software (developed by Pixmeo, SARL, Geneva; http://www.osirix-viewer.com) as the Digital Imaging and Communications in Medicine (DICOM) viewer. Briefly, as described by Bingham et al, 10 the LG area was measured from consecutive axial slices of orbital CT scans and added to obtain a final volume. The same protocol was applied to a group of 30 age-matched patients imaged for nonorbital pathology, which constituted the control group. The Wilcoxon signed-rank test was used to compare right and left LG volumes, and the ManneWhitney test was used to compare LG volumes between groups. The ManneWhitney U test was used to compare the Schirmer's test scores between eyes with nonmeasurable versus reduced LG. Finally, the Fisher exact test was used to analyze the association between the signs of keratopathy and LG size categorized as reduced and nonmeasurable. In all these tests, a P value 0.05 was considered significant.
DNA Amplification and Exon Sequencing
Sixteen patients were submitted to exon sequencing of the FOXL2 gene. Genomic DNA was extracted from peripheral blood leukocytes using a QIAamp DNA Blood isolation kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. For the analysis of the FOXL2 gene, 3 pairs of primers were designed to cover the entire FOXL2 exon and its splice site junctions ( Table 1) . The polymerase chain reactioneamplified DNA fragments were subjected to direct sequencing using the automatic capillary sequencing system ABI 3500X Genetic Analyzer (Applied Biosystems, Foster City, CA) and the Big Dye terminator v3.1 cycle sequencing kit (Applied Biosystems) according to the manufacturer's instructions. The results were analyzed using the FinchTV version 1.4.0 software (Geospiza, Seattle, WA); the sequences obtained were compared with the reference from GenBank database (NM_023067), and the mutation nomenclature was used according to Human Genome Variation Society guidelines (http://www.hgvs.org/mutnomen). Pathogenic scores for missense mutations were calculated using the prediction tools SIFT, 11 MutPred, 12 and MutationTaster. 13 
GenotypeeLacrimal Gland Phenotype Correlation
To identify a possible genotypeephenotype correlation, 2 groups of mutations were considered: those affecting protein size or its functional domain and those not affecting the protein catalytic domain or its structure. Fisher exact test was used to determine the significance of the association between these 2 categories of mutations and LG abnormalities. A P value 0.05 was considered significant.
Results
Clinical and molecular data are shown in LG ipsilaterally, and in the remaining 2 eyes, the LG size was markedly reduced. A significant difference was found between the Schirmer's scores in absent versus reduced LG cases (P ¼ 0.0006). Figure 1 shows the distribution of Schirmer's scores versus LG volumes. Eleven of the 14 eyes (78.6%) with absent LG showed Schirmer's values below the 10-mm cut off. In the group with reduced LG volumes, the Schirmer's scores were highly variable ranging from 3 to 35 mm. All the patients with normal LG presented normal Schirmer's values. A Schirmer's score less than 10 mm had a sensitivity of 68.4% to identify an LG volume of less than 0.20 cm 3 (Fig 1) . Finally, the Fisher exact test revealed that the presence of SPK was significantly associated with an absent LG (P ¼ 0.0007).
Orbital CT scans disclosed LG agenesis in 11 patients, 9 (42.8%) bilaterally and 2 unilaterally. Figure 2 shows examples of the morphologic LG variants detected. With the exception of 3 patients (6 glands), all LG volumes were reduced and below the minimum value measured in the control group (Table 2 ). In regard to only patients with BPES with measurable LG (Fig 3) 10 The ManneWhitney test showed that the volumes of patients with BPES were significantly lower than in the control (P < 0.05) for both the right and left orbits.
Molecular Investigation
Molecular screening of the FOXL2 gene showed pathogenic sequence variants in 13 (81.2%) of the 16 patients analyzed (Fig 4 ; 
*Comparative analysis with the control group: reduced when below and N when above the minimum value measured in the control group. Table 2 ). Eight distinct mutations were found, 4 of them previously unreported.
The most frequent mutation in this study was the in-frame duplication of 30 nucleotides, c.672_701dup30, resulting in a polyalanine expansion (p.A224-A234dup) that was detected in 5 patients (patients 1, 2, 7, 15, and 16) from 3 distinct families. Three missense mutations also were detected (c.650C>G, c.292T>G, c.313A>C), the last 2 in the DNA-binding forkhead domain of the gene.
Two in-frame insertions (c.919_920insACCGCCGC and c.768-769insG), a nonsense mutation (c.370A>T), and an in-frame deletion (c.172_176delTCGTA) were also found. All 4 interfered with the stop codon position; 3 of them led to a premature stop codon location (and abnormally small proteins), and the insertion from patient 12, c.768-769insG, deleted the wild-type stop codon of the gene, producing a hyper-long protein. Mutations c.172_176delTCGTA, c.370A>T, c.768-769insG, and c.313A>C from patients 9, 11, 12, and 13/14, respectively, were not previously described in BPES. The methodology used did not show any pathogenic mutations in 3 unrelated patients.
GenotypeeLacrimal Gland Phenotype Association
Six distinct mutations were associated with a more severe lacrimal phenotype, including absent or significantly reduced LG size and tear hyposecretion. These mutations comprised sequence variants inducing premature stop codons (c.172_176delTCGTA, c.919_920insACCGCCGC, and c.370A>T) or interfering with the wild-type one (c.768-769insG), and missense mutations located in the DNA-binding forkhead domain (c.292T>G, c.313A>C). The Fisher exact test showed a higher probability for these mutations to be associated with agenesis or underdevelopment of the gland (P ¼ 0.021).
Lighter phenotypes, with LG volumes within or near control group values and normal tear evaluation, were detected in association with alanine expansions (c.672_701dup30) and a missense mutation just before the polyalanine tract of the FOXL2 gene (c.650C>G).
In 3 unrelated patients, the gene sequence was normal. Two of these cases presented bilateral or unilateral LG agenesis (patients 3 and 4, respectively), and in the remaining one the gland was normal.
Discussion
The clinical presentation of BPES has been extensively described.
14 In addition to the classic signs of ptosis, epicanthus inversus and telecanthus, a variety of ophthalmic and nonophthalmic features 15e20 are variably associated with the syndrome. Deficiency of the tear production apparatus has been overlooked. To our knowledge, there are only 2 case reports of lacrimal hyposecretion. Athappilly and Braverman 21 described a 9-month-old female patient with BPES and bilateral absence of the LG. More recently, another 9-month-old infant with BPES was found to have absent tear production though normal-sized LGs were visible on ultrasound imaging. 22 The present report is the first to show that the association between alacrima and BPES is not incidental. In our group of patients, 52.3% had no measurable LGs (42.8% bilaterally and 9.5% unilaterally), and 33% of the remaining cases showed reduced LG volume. Not surprisingly, there was a clear association between these radiologic findings and tear hyposecretion.
A genotypeephenotype correlation has not been proven as yet in BPES. 23 So far, more than 100 different mutations have been described involving FOXL2, and pathogenic variants can be found in approximately 88% of cases. 24 The presence of other loci causing the syndrome also has been proposed, although a clear association is still lacking. 17, 25, 26 We performed molecular screening of FOXL2 in 16 patients to analyze specifically the LG phenotype. Thirteen patients (81%) showed pathogenic genetic changes, 4 of them already described by other authors [27] [28] [29] [30] and the remaining 4 being novel mutations. The most frequent mutation was a 30-nucleotide duplication (c.672e 701dup30) causing an expansion of 10 alanine residues (p.A224e234dup) within the polyalanine tract (Fig 4) . This mutation is responsible for a shift in the protein location from the nucleus, where it is normally located, to the cytoplasm, and induces a strong tendency to aggregation. 31 In our study, the same type of alanine duplication was found in 2 distinct families (1 of them Portuguese and the other Brazilian) and in 1 Brazilian sporadic case. This genetic defect is, in fact, recurrent and has been reported in distinct families with different geographic and ethnic backgrounds. 27 We found 3 missense mutations, 2 of them, c.650C>G and c.292T>G, already known. The first 28 leads to a switch from the amino acid serine to cysteine, immediately upstream from the polyalanine domain. This substitution presumably acts as a loss-of-function mutation, producing hypomorphic or null alleles and haploinsufficiency. 29 The latter is a change from a tryptophan to a glycine within the forkhead domain of FOXL2, a more common location for missense mutations in BPES, and causes nuclear and cytoplasmic protein aggregation. 32 The third missense mutation (c.313A>C), found in 2 related patients, is a novel pathogenic variant and causes the substitution of an asparagine for a histidine in the forkhead domain of FOXL2. 24 The remaining 4 mutations included 2 insertions, c.919_920insACCGCCGC and c.768-769insG, a nonsense mutation, c.370A>T, and a deletion, c.172_176delTCGTA. Only the first insertion has been described. 30 By taking into consideration only the LG phenotype and the mutation data, our data suggest that there is an association between the type of mutation and its location and LG abnormality. This finding needs to be corroborated by the evaluation of larger samples.
Overall, lower Schirmer scores in patients with BPES are highly suspicious for LG underdevelopment or even agenesia. The majority of patients with absent LG presented subnormal Schirmer scores. Nonetheless, 3 eyes with not measurable LG displayed values above the 10-mm cut off. We believe that these higher scores might be the result of the presence of small amounts of lacrimal tissue indistinguishable in the CT scan. The LG is surrounded by numerous structures with different radiologic densities, which make the identification of a small quantity of lacrimal tissue difficult, even for trained radiologists.
In the group of eyes with reduced LG volumes, Schirmer scores were highly variable. One patient with very small
LGs (patient 11) presented low scores; however, in the 
remaining eyes there was not a clear relationship between
LG size and Schirmer test. Some eyes with near-normal LG size displayed low Schirmer scores. When interpreting these results, one should keep in mind the unreliable nature and high variability of the Schirmer test. 33 Besides that, our data combined with a previous reported case of alacrima in a child with BPES and normal-sized LG 22 might indicate that FOXL2 mutations have an impact not only in the size but also in the gland's function.
Three patients (numbers 6, 7, and 20) displayed normal LG volumes. Schirmer test was performed in 2 of these patients with normal scores. We could not find an association between normal-sized LG and the molecular results. One of the patients (number 6) did not have an identifiable mutation, patient 7 presented the alanine expansion c.672e701dup30, also associated with reduced size LG (Table 2) , and in patient 20 the genetic screening was not performed.
The prevalence of LG underdevelopment in BPES remains unknown. In a previous study involving clinical, radiologic, and genetic analysis of 33 Indian patients with BPES, Chawla et al 17 used CT scans to study bone development and to compare orbital biometry with age-matched controls. No changes were detected in the LGs, which were reported to be apparently normal. We believe that a more accurate analysis of glandular volumes probably could show significant differences compared with the age-matched control group. However, it is interesting to notice that the rate of intragenic mutations in this group of patients with BPES was only 4% (1/25), which is below the usually reported rate of 72% in western countries. 30 As Chawla et al 17 suggest, this may have an ethnic reason, with the existence of other locus not yet described responsible for this distinct genetic background.
Considering our results, we must emphasize the importance of LG agenesis for the surgical management of BPES. There is a significant burden for the parents of affected children, who are usually extremely concerned about the abnormal appearance of the patients and exert a tremendous pressure for early cosmetic rehabilitation. Although there is no consensus about the best surgical strategy for the correction of the multiple palpebral fissure anomalies in BPES, 14 early ptosis surgery may be needed to alleviate the chin position and avoid visual deprivation. 34 Ptosis in BPES is generally severe, with poor to zero levator function, and most authors recommend bilateral frontalis slings. Supramaximal levator resection 35 and frontalis muscle flaps 36, 37 have been attempted with variable results. For these reasons, a reduced tear production is a serious concern for the long-term effects of ptosis correction on the ocular surface, because it seems reasonable to accept that spontaneous blink amplitude might be reduced after all these different modalities of surgery. 38 In addition, a certain degree of nocturnal lagophthalmos is the rule after congenital ptosis surgery, increasing the odds of corneal complications. In our cohort, all patients with demonstrable LG absence had persistent SPK; however, we cannot ignore the influence of postsurgical lagophthalmos in this corneal staining.
In conclusions, tear film evaluation often is neglected in children with BPES mainly because of the low position of the upper lid and the lack of cooperation. Nevertheless, our findings support the need for a careful preoperative evaluation of the lacrimal production status in all patients with BPES. If there is any sign of SPK or a history of tear absence when crying, orbital imaging should be considered to confirm LG underdevelopment.
